Market Overview

Hypoglycemia| A Drug Pipeline Analysis Report 2018| Technavio

Share:

Technavio has announced their latest analysis report on drug pipeline
for hypoglycemia.
The report includes a detailed analysis of the pipeline molecules under
investigation within the defined data collection period to treat
hypoglycemia.

This press release features multimedia. View the full release here:
https://www.businesswire.com/news/home/20180802005794/en/

Technavio has published a new report on the drug development pipeline for hypoglycemia, including a  ...

Technavio has published a new report on the drug development pipeline for hypoglycemia, including a detailed study of the pipeline molecules. (Graphic: Business Wire)

This report by Technavio
presents a detailed analysis of the market, including regulatory
framework, drug development strategies, recruitment strategies, and key
companies that are expected to play an essential role in the growth of
the market.

This report is available at a USD 1,000 discount for a limited time
only:
View
market snapshot before purchasing

Hypoglycemia: Market overview

Hypoglycemia is caused by abnormally low blood sugar (blood glucose)
levels. It is described as a condition in which the glucose level in the
blood falls below the normal level. The condition is related to the
treatment of diabetes. Hypoglycemia often makes an individual feel weak.
The symptoms of hypoglycemia include confusion, dizziness, feeling
shaky, hunger, headaches, and irritability. The severity of hypoglycemia
may vary from one person to another, and it can develop in both children
and adults, especially those with diabetes.

According to a senior market research analyst at Technavio, "As per
National Center for Chronic Disease Prevention and Health Promotion, the
estimated number of emergency visits in the US with hypoglycemia as the
first-listed diagnosis and diabetes as the secondary diagnosis was
stable between 2006 and 2009."

Hypoglycemia: Segmentation analysis

This pipeline analysis report segments the hypoglycemia market based on
therapies employed (monotherapy), RoA (subcutaneous, parenteral,
intravenous, oral, and intranasol), therapeutic modality (peptide, small
molecule, and monoclonal antibody), targets (glucose receptor, GLP-1,
SSTR2, and INSR), MoA (glucose receptor agonist, GLP-1 antagonist, SSTR2
antagonist, and INSR antagonist), geographical segmentation (US and
Japan) and recruitment status (recruiting). It provides an in-depth
analysis of the prominent factors influencing the market, including
drivers, opportunities, trends, and industry-specific challenges.

Based on the route of administration, 60% of the molecules that are
being investigated for the treatment of hypoglycemia are through
subcutaneous mode. The drug is delivered directly into the layer of the
skin below the dermis and epidermis.

Looking for more information on this market? Request
a free sample report

Technavio's sample reports are free of charge and contain multiple
sections of the report such as the market size and forecast, drivers,
challenges, trends, and more.

Some of the key topics covered in the report include:

Scope of the Report

Regulatory Framework

Drug Development Landscape

  • Drugs under development
  • Indications coverage

Drug Development Strategies

  • Therapies employed
  • RoA
  • Therapeutic modality
  • Geographical coverage

Recruitment Strategies

  • Recruitment status
  • Gender
  • Age

Key Companies

  • Type of players
  • Company overview

Discontinued or Dormant Molecules

About Technavio

Technavio
is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio's comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team
at media@technavio.com.

View Comments and Join the Discussion!